uniQure N.V.

NASDAQ: QURE
$4.82
+$0.15 (+3.2%)
Closing price April 22, 2024
uniQure N.V., based in Amsterdam, specializes in pioneering gene therapies for rare and severe diseases. Its notable product, HEMGENIX, targets hemophilia B and has successfully completed a crucial Phase III trial. The company is also advancing treatments for Huntington’s disease, ALS, temporal lobe epilepsy, Fabry disease, Alzheimer’s, and Parkinson’s through various stages of clinical and preclinical development. Founded in 1998, uniQure is at the forefront of genetic medicine, aiming to transform the lives of patients with groundbreaking treatments.

Tuesday's Top Analyst Upgrades and Downgrades: Ally Financial, Apple, Block, DR Horton, EOG, Ford, Micron, PayPal, Pfizer and More
Tuesday's top analyst upgrades and downgrades included Ally Financial, Apple, Ardelyx, Block, DocuSign, D.R. Horton, Enovix, EOG Resources, Ford, Futu, Micron Technology, Novavax, PayPal, Pfizer and...
Lee Jackson
Published:

Thursday's Top Analyst Upgrades and Downgrades: Adobe, American Airlines, Coupa Software, Disney, Host Hotels, Nio, Roblox, SentinelOne and More
Thursday's top analyst upgrades and downgrades included Adobe, American Airlines, Coupa Software, Delta Air Lines, Host Hotels & Resorts, Nio, Novo Nordisk, Ralph Lauren, Roblox, SentinelOne and Walt...
Lee Jackson
Published:

Alliance Data, Cimarex Energy, Myriad Genetics, Nestle and More Tuesday Afternoon Analyst Research Calls
Alliance Data, Cimarex Energy, Myriad Genetics and Nestle were among Tuesday afternoon's analyst upgrades and downgrades.
Lee Jackson
Published:

Friday's Top Analyst Upgrades and Downgrades: AT&T, Cisco, Dish Network, Energy Transfer, Splunk, Virgin Galactic and More
Friday's top analyst upgrades and downgrades included AT&T, Cisco Systems, Datadog, Dish Network, Energy Transfer, Pioneer Natural Resources, Splunk and Virgin Galactic.
Lee Jackson
Published:

Top Analyst Upgrades and Downgrades: Carnival, Dow, Goldman Sachs, Micron, Netflix, Oracle, Snap, Spotify, Twitter and More
Thursday's top analyst upgrades and downgrades included Carnival, Dow, Goldman Sachs, Micron Technology, Netflix, Oracle, Snap, Spotify and Twitter.
Lee Jackson
Published:

5 Top Biotech Stocks to Buy for 2021 With Massive Upside Potential
A new Stifel research report includes the firm's biotech stock picks for 2021. These five have the biggest upside to the posted price targets and are best suited for patient, aggressive growth...
Lee Jackson
Published:

Raymond James Top Health Care Picks Crushing S&P 500: 4 Stocks to Buy Now
Health care has been a top performer this year, and there is every reason to believe that performance will carry through into 2021. These are four of the highest-ranked health care ideas from the...
Lee Jackson
Published:

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Beyond Meat, CommScope, Enphase, Nabors, Netflix, Nike, Roku, Tesla, Uber, Williams Companies and More
Tuesday's top analyst upgrades, downgrades and initiations included Alphabet, Amazon.com, Beyond Meat, CommScope, Enphase Energy, Nabors Industries, Netflix, Nike, Roku, Tesla, Uber Technologies and...
Jon C. Ogg
Published:
Last Updated:

8 Secondary Stock Offerings Total Up to $3 Billion That Has to Be Sold
Here are eight secondary offerings that have been filed with a grand tally of about $3 billion combined.
Jon C. Ogg
Published: